metformin has been researched along with Acne in 29 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study compared the efficacy of metformin and doxycycline in treating patients with acne vulgaris." | 9.69 | Efficacy of metformin vs. doxycycline in treating acne vulgaris: An assessor-blinded, add-on, randomized, controlled clinical trial. ( Javaheri, R; Parvizi, MM; Sadati, MS; Shahriarirad, R; Yazdanpanah, N, 2023) |
| " Metformin, through inhibition of mTORC1 may improve acne." | 9.30 | Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris: A randomized open-labeled study. ( Kwan, Z; Robinson, S; Tang, MM, 2019) |
| "There was heterogeneity across some studies due to different acne assessment scales, metformin dosages, and treatment durations." | 9.12 | Metformin Therapy for Acne in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis. ( Chang, YT; Huang, YC; Yee, FJ; Yen, H, 2021) |
| "The purpose of this literature review is to evaluate the use of metformin as an adjunct therapy in the treatment of moderate-to-severe acne in those not diagnosed with polycystic ovary syndrome (PCOS) or androgen excess." | 8.95 | Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris. ( Lee, JK; Smith, AD, 2017) |
| "The object of this review was to compare metformin versus oral contraceptive pill (OCP) treatment in polycystic ovary syndrome." | 8.84 | Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review. ( Costello, MF; Eden, J; Johnson, NP; Shrestha, B; Sjoblom, P, 2007) |
| " Metformin is commonly used for treatment of acne in patients with polycystic ovarian syndrome (PCOS)." | 8.31 | Effects of metformin on clinical, hormonal and relevant gene expression parameters in patients with acne: an observational study. ( De, D; Dutta, P; Handa, S; Kamboj, P; Kaushik, A; Pal, A; Saikia, UN, 2023) |
| "To evaluate the role of metformin in the treatment of acne vulgaris by reducing the level of insulin-like growth factor 1." | 8.12 | The potential role of insulin-like growth factor 1 in acne vulgaris and its correlation with the clinical response before and after treatment with metformin. ( Abd-Elaal, WH; AbouHadeed, MH; Albalat, W; Darwish, H; Essam, R, 2022) |
| "Evidence for the effectiveness of metformin in the treatment of acne is limited." | 8.02 | Effects of metformin on experimentally induced acne on rabbit ear. ( Bishnoi, A; De, D; Dutta, P; Handa, S; Kamboj, P; Nahar Saikia, U; Pal, A, 2021) |
| "Treatment with metformin three times 500 mg daily had been advised since 2002, to patients suffering from the polycystic ovary syndrome diagnosed by the Rotterdam criteria and who did not want to take contraceptive pills." | 7.77 | [Metformin treatment with or without life style changes in patients with polycystic ovary syndrome]. ( Petrányi, G; Zaoura-Petrányi, M, 2011) |
| "Acne is a common and complex skin disease, with a very complex pathogenesis." | 6.82 | Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments. ( Colao, A; Del Prete, M; Donnarumma, M; Fabbrocini, G; Faggiano, A; Izzo, R; Marasca, C; Marciello, F; Monfrecola, G; Savastano, R, 2016) |
| "Metformin was then given at a dose of 500 mg three times a day for 8 weeks, after which time the pretreatment study was repeated." | 6.71 | Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. ( Dehghan-Kooshkghazi, M; Kazerooni, T, 2003) |
| "Hirsutism is a common and distressing symptom frequently encountered in women with polycystic ovary syndrome (PCOS), who also show relative insulin resistance." | 6.71 | Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. ( Fleming, R; Harborne, L; Lyall, H; Norman, J; Sattar, N, 2003) |
| "Metformin and OCPs were similar in terms of impact on hirsutism." | 6.53 | Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis. ( Al Khalifah, RA; Bassilious, E; Dennis, B; Florez, ID; Thabane, L, 2016) |
| " Metformin, through inhibition of mTORC1 may improve acne." | 5.30 | Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris: A randomized open-labeled study. ( Kwan, Z; Robinson, S; Tang, MM, 2019) |
| "There was heterogeneity across some studies due to different acne assessment scales, metformin dosages, and treatment durations." | 5.12 | Metformin Therapy for Acne in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis. ( Chang, YT; Huang, YC; Yee, FJ; Yen, H, 2021) |
| "The purpose of this literature review is to evaluate the use of metformin as an adjunct therapy in the treatment of moderate-to-severe acne in those not diagnosed with polycystic ovary syndrome (PCOS) or androgen excess." | 4.95 | Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris. ( Lee, JK; Smith, AD, 2017) |
| "The object of this review was to compare metformin versus oral contraceptive pill (OCP) treatment in polycystic ovary syndrome." | 4.84 | Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review. ( Costello, MF; Eden, J; Johnson, NP; Shrestha, B; Sjoblom, P, 2007) |
| " Metformin is commonly used for treatment of acne in patients with polycystic ovarian syndrome (PCOS)." | 4.31 | Effects of metformin on clinical, hormonal and relevant gene expression parameters in patients with acne: an observational study. ( De, D; Dutta, P; Handa, S; Kamboj, P; Kaushik, A; Pal, A; Saikia, UN, 2023) |
| "The aim of the study was to investigate immune-mediated (urticaria, allergic contact dermatitis, and psoriasis) and androgen-mediated (acanthosis nigricans, hidradenitis suppurativa, and acne) skin diseases associated with metformin use." | 4.31 | Differential Effects of Metformin on Immune-Mediated and Androgen-Mediated Non-Cancer Skin Diseases in Diabetes Patients: A Retrospective Cohort Study. ( Tseng, CH, 2023) |
| "Evidence for the effectiveness of metformin in the treatment of acne is limited." | 4.02 | Effects of metformin on experimentally induced acne on rabbit ear. ( Bishnoi, A; De, D; Dutta, P; Handa, S; Kamboj, P; Nahar Saikia, U; Pal, A, 2021) |
| "Treatment with metformin three times 500 mg daily had been advised since 2002, to patients suffering from the polycystic ovary syndrome diagnosed by the Rotterdam criteria and who did not want to take contraceptive pills." | 3.77 | [Metformin treatment with or without life style changes in patients with polycystic ovary syndrome]. ( Petrányi, G; Zaoura-Petrányi, M, 2011) |
| "Metformin is an established staple drug in the management of Type 2 diabetes mellitus." | 3.01 | A systematic review of the uses of metformin in dermatology. ( Al-Niaimi, F; Ali, FR; Raza, S, 2023) |
| "Acne is a common and complex skin disease, with a very complex pathogenesis." | 2.82 | Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments. ( Colao, A; Del Prete, M; Donnarumma, M; Fabbrocini, G; Faggiano, A; Izzo, R; Marasca, C; Marciello, F; Monfrecola, G; Savastano, R, 2016) |
| "Metformin was then given at a dose of 500 mg three times a day for 8 weeks, after which time the pretreatment study was repeated." | 2.71 | Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. ( Dehghan-Kooshkghazi, M; Kazerooni, T, 2003) |
| "Hirsutism is a common and distressing symptom frequently encountered in women with polycystic ovary syndrome (PCOS), who also show relative insulin resistance." | 2.71 | Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. ( Fleming, R; Harborne, L; Lyall, H; Norman, J; Sattar, N, 2003) |
| "Metformin and OCPs were similar in terms of impact on hirsutism." | 2.53 | Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis. ( Al Khalifah, RA; Bassilious, E; Dennis, B; Florez, ID; Thabane, L, 2016) |
| "Metformin was less effective than the OCP in improving menstrual pattern (Peto odds ratio (OR) 0." | 2.44 | Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. ( Costello, M; Eden, J; Johnson, N; Shrestha, B; Sjoblom, P, 2007) |
| "Polycystic ovary syndrome is a multi-system endocrinopathy with long-term metabolic and cardiovascular health consequences." | 2.43 | Contemporary medical therapy for polycystic ovary syndrome. ( Domino, SE; Lanham, MS; Lebovic, DI, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (31.03) | 29.6817 |
| 2010's | 11 (37.93) | 24.3611 |
| 2020's | 9 (31.03) | 2.80 |
| Authors | Studies |
|---|---|
| Albalat, W | 1 |
| Darwish, H | 1 |
| Abd-Elaal, WH | 1 |
| AbouHadeed, MH | 1 |
| Essam, R | 1 |
| Raza, S | 1 |
| Al-Niaimi, F | 1 |
| Ali, FR | 1 |
| Kamboj, P | 2 |
| Kaushik, A | 1 |
| Handa, S | 2 |
| Dutta, P | 2 |
| Saikia, UN | 1 |
| Pal, A | 2 |
| De, D | 2 |
| Tseng, CH | 1 |
| Sadati, MS | 1 |
| Yazdanpanah, N | 1 |
| Shahriarirad, R | 1 |
| Javaheri, R | 1 |
| Parvizi, MM | 1 |
| Xiong, T | 1 |
| Fraison, E | 1 |
| Kolibianaki, E | 1 |
| Costello, MF | 2 |
| Venetis, C | 1 |
| Kostova, EB | 1 |
| Yen, H | 1 |
| Chang, YT | 1 |
| Yee, FJ | 1 |
| Huang, YC | 1 |
| Chang, JE | 1 |
| Choi, MS | 1 |
| Bishnoi, A | 1 |
| Nahar Saikia, U | 1 |
| Lepine, S | 1 |
| Jo, J | 1 |
| Metwally, M | 1 |
| Cheong, YC | 1 |
| Lee, JK | 1 |
| Smith, AD | 1 |
| Robinson, S | 1 |
| Kwan, Z | 1 |
| Tang, MM | 1 |
| Roberts, TK | 1 |
| Fantz, CR | 1 |
| Buzney, E | 1 |
| Sheu, J | 1 |
| Buzney, C | 1 |
| Reynolds, RV | 1 |
| Fabbrocini, G | 1 |
| Izzo, R | 1 |
| Faggiano, A | 1 |
| Del Prete, M | 1 |
| Donnarumma, M | 1 |
| Marasca, C | 1 |
| Marciello, F | 1 |
| Savastano, R | 1 |
| Monfrecola, G | 1 |
| Colao, A | 1 |
| Al Khalifah, RA | 1 |
| Florez, ID | 1 |
| Dennis, B | 1 |
| Thabane, L | 1 |
| Bassilious, E | 1 |
| Ding, T | 1 |
| Baio, G | 1 |
| Hardiman, PJ | 1 |
| Petersen, I | 1 |
| Sammon, C | 1 |
| Klein, F | 1 |
| Langmár, Z | 1 |
| Bergstrom, KG | 1 |
| Petrányi, G | 1 |
| Zaoura-Petrányi, M | 1 |
| Kazerooni, T | 1 |
| Dehghan-Kooshkghazi, M | 1 |
| Harborne, L | 1 |
| Fleming, R | 1 |
| Lyall, H | 1 |
| Sattar, N | 1 |
| Norman, J | 1 |
| Heymann, WR | 1 |
| Ehrmann, DA | 1 |
| Lanham, MS | 1 |
| Lebovic, DI | 1 |
| Domino, SE | 1 |
| Costello, M | 1 |
| Shrestha, B | 2 |
| Eden, J | 2 |
| Sjoblom, P | 2 |
| Johnson, N | 1 |
| Johnson, NP | 1 |
| Homburg, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Descriptive, Transversal Study of Evaluation of Cardiovascular Risks Factors and Prevalence of Metabolic Syndrome in the Different Phenotypes of Women With Polycystic Ovary Syndrome[NCT00784615] | 80 participants (Anticipated) | Observational | 2007-12-31 | Recruiting | |||
| Clinical Metabolic and Endocrine Parameters in Response to Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome: A Phase 4 Randomized, Double- Blind and Placebo Control Trial[NCT00679679] | Phase 4 | 30 participants (Actual) | Interventional | 2003-01-31 | Completed | ||
| Efficacy and Safety of Furocyst in Patients With Poly Cystic Ovary Syndrome[NCT02789488] | Phase 4 | 50 participants (Actual) | Interventional | 2013-09-30 | Completed | ||
| Anxiety and Sexual Malfunction in Infertile Polycystic Ovarian Syndrome Patients[NCT05056272] | 128 participants (Anticipated) | Observational | 2022-01-01 | Recruiting | |||
| The Impact of Continuous Aerobic Exercise and High-Intensity Interval Training on Reproductive Outcomes in Polycystic Ovary Syndrome: A Pilot Randomized Controlled Trial.[NCT03362918] | 60 participants (Actual) | Interventional | 2018-01-01 | Completed | |||
| Adipose Tissue Angiogenesis in Polycystic Ovary Syndrome (PCOS)[NCT01745471] | 36 participants (Anticipated) | Observational | 2012-12-06 | Active, not recruiting | |||
| The Effects of Contraceptive Pill and Hormonal Vaginal Ring on Hormonal, Inflammatory and Metabolic Parameters in Women of Reproductive Age With Polycystic Ovary Syndrome (PCOS).[NCT01588873] | Phase 4 | 42 participants (Anticipated) | Interventional | 2012-04-30 | Recruiting | ||
| Pilot Study on the Effects of Fasting Mimicking Diet (FMD) in Women With Polycystic[NCT05196568] | 100 participants (Anticipated) | Interventional | 2021-07-01 | Active, not recruiting | |||
| Is the Co-administration of Metformine and CC as Compared to Placebo and CC Superior to Induce Ovulation in PCOS Patients With a Confirmed insulin-resistant-a Double Blind Randomized Clinical Trial[NCT02523898] | Phase 2 | 388 participants (Anticipated) | Interventional | 2015-11-30 | Enrolling by invitation | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
13 reviews available for metformin and Acne
| Article | Year |
|---|---|
A systematic review of the uses of metformin in dermatology.
Topics: Acne Vulgaris; Dermatology; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Metformi | 2023 |
Statins for women with polycystic ovary syndrome not actively trying to conceive.
Topics: Acne Vulgaris; Contraceptives, Oral; Female; Hirsutism; Humans; Hydroxymethylglutaryl-CoA Reductase | 2023 |
Metformin Therapy for Acne in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.
Topics: Acne Vulgaris; Androgen Antagonists; Drug Therapy, Combination; Female; Humans; Metformin; Non-Rando | 2021 |
A Molecular Perspective on the Potential Benefits of Metformin for the Treatment of Inflammatory Skin Disorders.
Topics: Acanthosis Nigricans; Acne Vulgaris; Dermatitis, Allergic Contact; Hidradenitis Suppurativa; Humans; | 2020 |
Ovarian surgery for symptom relief in women with polycystic ovary syndrome.
Topics: Acne Vulgaris; Clomiphene; Female; Gonadotropins; Hirsutism; Humans; Laparoscopy; Letrozole; Menstru | 2017 |
Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Anti-Bacterial Agents; Benzoyl Peroxide; Combined Modality Therapy; Dermat | 2017 |
Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Alopecia; Androgen Antagonists; Contraceptives, Oral, C | 2014 |
Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis.
Topics: Acne Vulgaris; Adolescent; Body Mass Index; Contraceptives, Oral; Female; Glucose Metabolism Disorde | 2016 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Cardiovascular Diseases; Chromans; Contraceptives, Oral; Diabet | 2005 |
Contemporary medical therapy for polycystic ovary syndrome.
Topics: Acne Vulgaris; Adult; Clomiphene; Estrogen Antagonists; Female; Hirsutism; Humans; Hypoglycemic Agen | 2006 |
Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
Topics: Acne Vulgaris; Cardiovascular Diseases; Contraceptives, Oral, Combined; Endometrial Neoplasms; Femal | 2007 |
Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review.
Topics: Acne Vulgaris; Adult; Cardiovascular Diseases; Contraceptives, Oral, Combined; Female; Hirsutism; Hu | 2007 |
Polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Aromatase Inhibitors; Clomiphene; Female; Fertility Agents, Fem | 2008 |
5 trials available for metformin and Acne
| Article | Year |
|---|---|
Efficacy of metformin vs. doxycycline in treating acne vulgaris: An assessor-blinded, add-on, randomized, controlled clinical trial.
Topics: Acne Vulgaris; Double-Blind Method; Doxycycline; Gels; Humans; Immunoglobulin A; Insulin-Like Growth | 2023 |
Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris: A randomized open-labeled study.
Topics: Acne Vulgaris; Adolescent; Adult; Benzoyl Peroxide; Dermatologic Agents; Drug Therapy, Combination; | 2019 |
Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments.
Topics: Acne Vulgaris; Adolescent; Adult; Combined Modality Therapy; Diet, Reducing; Glucose; Glycemic Index | 2016 |
Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Topics: Acne Vulgaris; Adolescent; Adult; Blood Glucose; Body Mass Index; Dehydroepiandrosterone Sulfate; Fa | 2003 |
Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.
Topics: Acne Vulgaris; Androgen Antagonists; Anthropometry; Blood Glucose; Blood Pressure; Body Mass Index; | 2003 |
11 other studies available for metformin and Acne
| Article | Year |
|---|---|
The potential role of insulin-like growth factor 1 in acne vulgaris and its correlation with the clinical response before and after treatment with metformin.
Topics: Acne Vulgaris; Adolescent; Adult; Humans; Insulin-Like Growth Factor I; Metformin; Young Adult | 2022 |
Effects of metformin on clinical, hormonal and relevant gene expression parameters in patients with acne: an observational study.
Topics: Acne Vulgaris; Female; Gene Expression; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; In | 2023 |
Differential Effects of Metformin on Immune-Mediated and Androgen-Mediated Non-Cancer Skin Diseases in Diabetes Patients: A Retrospective Cohort Study.
Topics: Acne Vulgaris; Androgens; Diabetes Mellitus, Type 2; Hidradenitis Suppurativa; Humans; Metformin; Re | 2023 |
Effects of metformin on experimentally induced acne on rabbit ear.
Topics: Acne Vulgaris; Animals; Disease Models, Animal; Metformin; Outcome Assessment, Health Care; Rabbits | 2021 |
Easy bruising in a patient with secondary amenorrhea.
Topics: Acne Vulgaris; Adult; Amenorrhea; Contusions; Female; Hormones; Humans; Metformin; Polycystic Ovary | 2014 |
Diagnosis and management of polycystic ovary syndrome in the UK (2004-2014): a retrospective cohort study.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Drug Prescriptions; Female; Humans | 2016 |
[Polycystic ovary syndrome. Diet helps control hormone chaos].
Topics: Acne Vulgaris; Adolescent; Adult; Androgens; Child; Combined Modality Therapy; Female; Hirsutism; Hu | 2009 |
[Diagnosis and treatment of polycystic ovary syndrome].
Topics: Acne Vulgaris; Alopecia; Amenorrhea; Androgens; Clomiphene; Diabetes Complications; Diagnosis, Diffe | 2010 |
Everything old is new again: spironolactone and metformin in the treatment of acne.
Topics: Acne Vulgaris; Clinical Trials as Topic; Dermatologic Agents; Humans; Hypoglycemic Agents; Metformin | 2010 |
[Metformin treatment with or without life style changes in patients with polycystic ovary syndrome].
Topics: Acne Vulgaris; Adult; Body Mass Index; Caloric Restriction; Case-Control Studies; Drug Administratio | 2011 |
Hyperandrogenism and the skin.
Topics: Acne Vulgaris; Adrenal Hyperplasia, Congenital; Female; Humans; Hyperandrogenism; Male; Metformin; P | 2004 |